Log In
Print
BCIQ
Print
Print this Print this
 

CAL-120

  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionOral, small molecule, delta and beta isoform selective phosphoinositide 3-kinase (PI3K) inhibitor
Molecular Target Phosphoinositide 3-kinase (PI3K) delta ; Phosphoinositide 3-kinase (PI3K) beta
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumor malignancies
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today